Northwestern Medicine: 8th Annual Cardiovascular Update
Avatar

AF and Heart Failure: What’s the Risk? Is Ablation the Answer?

By Northwestern Medicine: 8th Annual Cardiovascular Update FEATURING Jonathan Piccini
August 14, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

32:12
Merck Cardiology

A Treatment Option for Heart Failure Patients With Reduced Ejection Fracti…

Feat. B. Hilkert, B. Colucci

Related Content

AUTOPLAY
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Fri, Jun 26, 2020
Faculty: Roderick Tung , Boston Scientific , David Haines
Boston Scientific
Incorporating Local Impedance Into Your RF Ablation Practice
Mon, Sep 14, 2020
Faculty: Christian Meyer , Roderick Tung , Boston Scientific , Suraj Kapa
Houston Methodist DeBakey Heart and Vascular Center

11th Annual Multimodality Cardiovascular Imaging for the Clinician

Sat, Dec 11, 2021
Northwestern Medicine Cardiovascular Care

17th Annual Heart Failure Holiday Symposium

Fri, Dec 10, 2021
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - How to…

14:44
26th Annual San Diego Heart Failure Symposium

Broadening Indications for the Use of Angiotensin Receptor Neprilysin Inhi…

Feat. C. Yancy
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhib…

Feat. B. Greenberg
21:28
Keck School of Medicine of USC

Takotsubo Syndrome: What Diagnostic Criteria Are Available? Which Drugs to…

Feat. H. Van Herle
12:23
American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Hospital…

Feat. M. Tipton
63:10
Cardiac Contractility Modulation

Failure Is not an Option! Implementing CCM into your Practice

Feat. F. Syed, M. Goldschmidt, I. Rao
64:40
Cardiac Contractility Modulation

CCM® Therapy - Mechanism of Action, Patient Selection and Identification

Feat. A. Kaplan, H. Saltzman
24:58
Boston Scientific

How to Manage HF using a Remote Heart Failure Diagnostic and Monitoring So…

Feat. J. Boehmer
05:10
Boston Scientific

HeartLogic™: The First FDA-Approved Predictive Analytic Alert in an Implan…

Feat. A. Hernandez, J. Boehmer, J. Singh, C. Fier, N. Albert
88:01
Cardiac Contractility Modulation

The Comparison and Advantages of the Use of Device Therapy in Heart Failur…

Feat. V. Thohan, G. Tomassoni, R. Doshi, F. Abi-Samra, I. Rao
51:47
Boston Scientific

Biophysics of Ablation – Fundamentals and Myths

Feat. R. Tung, D. Haines
61:12
Cardiac Contractility Modulation

Assessing Heart Failure Patients - Where Does CCM® Therapy Fit

Feat. S. Brune, N. Bonnet, M. Arnold
16:54
Cardiac Contractility Modulation

Cardiac Contractility Modulation: How it Works

Feat. J. Ehrlich, H. Levin
27:33
Boston Scientific

Multi-Sensor Heart Failure Monitoring: What Are the Benefits of HeartLogic…

Feat. J. Boehmer
33:38
Cardiac Contractility Modulation

AAHFN Advanced 2020 - CCM® in HF - Mechanism and Clinical Evidence

Feat. R. Kahwash, N. Albert
17:22
Getinge

IABP case study in Advance Heart Failure

Feat. J. Estep
20:23
Heart Failure 2021: An Update on Therapy

Use of Diuretics in Patients With Volume Overload: What to Do When You See…

Feat. J. Testani
17:09
Heart Failure 2021: An Update on Therapy

Peripartum Cardiomyopathy: Treatment Considerations in the Context of Yout…

Feat. M. Davis
06:27
Duy Nguyen

Applied Biophysics to Improve Radiofrequency Ablation

Feat. D. Nguyen
18:35
Heart Failure 2021: An Update on Therapy

SGLT2 Inhibitors for HF: What Is the Effect of Empagliflozin on Cardiovasc…

Feat. M. Packer